Literature DB >> 16784457

Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs.

Alexander V Mayorov1, So-Yeop Han, Minying Cai, Matthew R Hammer, Dev Trivedi, Victor J Hruby.   

Abstract

The effects of the linker arm rigidity and size on melanocortin receptor selectivity were explored in a series of compounds using cyclic lactam alpha-melanocyte-stimulating hormone template. A variety of dicarboxylic acid linkers introduced between the alpha-amino group of His(6) and the epsilon-amino group of Lys(10) lead to high-affinity, selective human melanocortin receptor-1 and -5 (hMC1R and hMC5R) antagonists. The incorporation of hydrophilic functions into the linker arm was found to be unfavorable for both binding potency and receptor selectivity. Analogs 8 and 9 containing highly conformationally constrained hydrophobic linkers (m- and p-phthalic acids) were found to be selective nanomolar range hMC1R antagonists (IC(50) = 7 and 4 nm, respectively), whereas the employment of a small conformationally constrained linker (maleic acid) resulted in a high-affinity (IC(50) = 19 nm) and selective hMC5R antagonist (analog 12). These newly developed melanotropins will serve as critical biochemical tools for elucidating the full spectrum of functions performed by the physiologically important melanocortin-1 and -5 receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784457      PMCID: PMC1851940          DOI: 10.1111/j.1747-0285.2006.00383.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  36 in total

1.  Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.

Authors:  Paolo Grieco; Antonio Lavecchia; Minying Cai; Devendra Trivedi; David Weinberg; Tanya MacNeil; L H T Van der Ploeg; Victor J Hruby
Journal:  J Med Chem       Date:  2002-11-21       Impact factor: 7.446

Review 2.  The melanocortin system.

Authors:  Ira Gantz; Tung M Fong
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-03       Impact factor: 4.310

3.  Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.

Authors:  Alexander V Mayorov; Minying Cai; Kevin B Chandler; Ravil R Petrov; April R Van Scoy; Zerui Yu; Dustin K Tanaka; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

4.  Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors.

Authors:  Malcolm J Kavarana; Dev Trivedi; Minying Cai; Jinfa Ying; Matthew Hammer; Christopher Cabello; Paolo Grieco; Guoxia Han; Victor J Hruby
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

5.  Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.

Authors:  M A Bednarek; T MacNeil; R Tang; R N Kalyani; L H Van der Ploeg; D H Weinberg
Journal:  Biochem Biophys Res Commun       Date:  2001-08-24       Impact factor: 3.575

6.  The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans.

Authors:  Jeffrey S Mogil; Sonya G Wilson; Elissa J Chesler; Andrew L Rankin; Kumar V S Nemmani; William R Lariviere; M Kristina Groce; Margaret R Wallace; Lee Kaplan; Roland Staud; Timothy J Ness; Toni L Glover; Magda Stankova; Alexander Mayorov; Victor J Hruby; Judith E Grisel; Roger B Fillingim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-27       Impact factor: 11.205

7.  Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction.

Authors:  H Wessells; D Gralnek; R Dorr; V J Hruby; M E Hadley; N Levine
Journal:  Urology       Date:  2000-10-01       Impact factor: 2.649

8.  Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist.

Authors:  G Han; J M Quillan; K Carlson; W Sadée; V J Hruby
Journal:  J Med Chem       Date:  2003-02-27       Impact factor: 7.446

9.  A role for the melanocortin 4 receptor in sexual function.

Authors:  Lex H T Van der Ploeg; William J Martin; Andrew D Howard; Ravi P Nargund; Christopher P Austin; Xiaoming Guan; Jennifer Drisko; Doreen Cashen; Iyassu Sebhat; Arthur A Patchett; David J Figueroa; Anthony G DiLella; Brett M Connolly; David H Weinberg; Carina P Tan; Oksana C Palyha; Sheng-Shung Pong; Tanya MacNeil; Charles Rosenblum; Aurawan Vongs; Rui Tang; Hong Yu; Andreas W Sailer; Tung Ming Fong; Cathy Huang; Michael R Tota; Ray S Chang; Ralph Stearns; Constantin Tamvakopoulos; George Christ; Deborah L Drazen; Brian D Spar; Randy J Nelson; D Euan MacIntyre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

Review 10.  The role of melanocortin peptides and receptors in regulation of energy balance.

Authors:  Ildiko Antal Zimanyi; Mary Ann Pelleymounter
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  12 in total

1.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

2.  Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Natalie M Barkey; Narges K Tafreshi; Jatinder S Josan; Channa R De Silva; Kevin N Sill; Victor J Hruby; Robert J Gillies; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2011-11-10       Impact factor: 7.446

3.  Utilize conjugated melanotropins for the earlier diagnosis and treatment of melanoma.

Authors:  Minying Cai; Zhonglin Liu; Hongchang Qu; Helen Fan; Zhiping Zheng; Victor J Hruby
Journal:  Eur J Pharmacol       Date:  2011-02-16       Impact factor: 4.432

4.  Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Zhihua Liu; James P Cain; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  Peptides       Date:  2010-08-03       Impact factor: 3.750

5.  Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.

Authors:  Lucas Doedens; Florian Opperer; Minying Cai; Johannes G Beck; Matt Dedek; Erin Palmer; Victor J Hruby; Horst Kessler
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

6.  Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor.

Authors:  Natalie M Barkey; Christian Preihs; Heather H Cornnell; Gary Martinez; Adam Carie; Josef Vagner; Liping Xu; Mark C Lloyd; Vincent M Lynch; Victor J Hruby; Jonathan L Sessler; Kevin N Sill; Robert J Gillies; David L Morse
Journal:  J Med Chem       Date:  2013-08-09       Impact factor: 7.446

7.  "Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.

Authors:  Molly E Martin; M Sue O'Dorisio; Whitney M Leverich; Kyle C Kloepping; Susan A Walsh; Michael K Schultz
Journal:  Recent Results Cancer Res       Date:  2013

8.  Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists.

Authors:  Paolo Grieco; Minying Cai; Lu Liu; Alexander Mayorov; Kevin Chandler; Dev Trivedi; Guangxin Lin; Pietro Campiglia; Ettore Novellino; Victor J Hruby
Journal:  J Med Chem       Date:  2008-04-15       Impact factor: 7.446

9.  In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

Authors:  Narges K Tafreshi; Ariosto Silva; Veronica C Estrella; Timothy W McCardle; Tingan Chen; Yolaine Jeune-Smith; Mark C Lloyd; Steven A Enkemann; Keiran S M Smalley; Vernon K Sondak; Josef Vagner; David L Morse
Journal:  Mol Pharm       Date:  2013-07-08       Impact factor: 4.939

10.  Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Narges K Tafreshi; Xuan Huang; Valerie E Moberg; Natalie M Barkey; Vernon K Sondak; Haibin Tian; David L Morse; Josef Vagner
Journal:  Bioconjug Chem       Date:  2012-11-27       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.